Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement Regarding Nomination of Robert F…
BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…
BIO Released the Following Statement After…
“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…
BIO Statement on Lawsuit Over 340B Rebates
BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…
All Press Releases
  • Show All
Search
Results
Event Tags
May 17, 2017
Washington, DC (May 17, 2017) – Today, the Biotechnology Innovation Organization (BIO) joins with a diverse coalition of stakeholders in endorsing a set of pro-competition, free-market-oriented solutions to lower healthcare costs while…
May 16, 2017
BIO submitted comments to the Environmental Protection Agency’s Regulatory Reform Task Force on Executive Order 13777 “Enforcing the Regulatory Reform Agenda.”
May 15, 2017
Termeer was a key architect in the founding of BIO, a mentor to countless entrepreneurs, executives and researchers, and passionate in his pursuit of innovative patient-centric drug development. Washington, DC (May 15, 2017) – Henri…
May 12, 2017
Washington, D.C. (May 12, 2017) – The Biotechnology Innovation Organization (BIO) issued the following statement regarding initial results of the 100-Day Action Plan of the U.S.-China Comprehensive Economic Dialogue:
May 11, 2017
Bio-based Technologies Address Human, Animal, Plant and Environmental Health Washington, D.C. (May 11, 2017) – At its heart, the concept of One Health is rooted in the notion that the health of humans, animals, and the environment are all…
May 10, 2017
Former First Lady of Massachusetts and New York Times best-selling author will speak about the power of resilience in overcoming obstacles, advocating for families and spearheading brain health research
May 9, 2017
Washington, DC (May 9, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the confirmation of Dr. Scott Gottlieb as Commissioner of the Food and Drug Administration (FDA):
May 4, 2017
BIO today thanked Sen. Ron Wyden (D-OR) and 21 Senate co-sponsors for proposing a technology neutral tax credit for domestic production of clean transportation fuel. Sen. Wyden’s Clean Energy for America Act proposes a set of long-term energy tax…
May 4, 2017
Washington, DC (May 4, 2017) – Today, the Biotechnology Innovation Organization (BIO) thanks Reps. Pat Meehan (R-PA), Richard Neal (D-MA), Mike Kelly (R-PA), Ron Kind (D-WI), and John Larson (D-CT) for introducing the Partnerships to Advance…
May 4, 2017
SBIR-funded companies will showcase biotechnology breakthroughs at BIO 2017 International Convention 
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.